Coronary Artery Disease de novo
Item
patients with clinically significant de novo coronary artery disease
boolean
C1956346 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
Stenting | Stent marketed product
Item
stenting only with endeavor® stents
boolean
C2348535 (UMLS CUI [1])
C0038257 (UMLS CUI [2,1])
C0683746 (UMLS CUI [2,2])
Length of stent | Lesion Quantity
Item
the sum of stent length is less than 60 mm for one lesion. the sum of stent length in multiple lesions does not matter.
boolean
C0449462 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Shock, Cardiogenic
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
ST segment elevation myocardial infarction Time of symptom onset
Item
st-elevation myocardial infarction within 48 hours of symptom onset
boolean
C1536220 (UMLS CUI [1,1])
C1320528 (UMLS CUI [1,2])
Implantation Drug-Eluting Stent
Item
prior implantation of drug-eluting stents
boolean
C0021107 (UMLS CUI [1,1])
C1322815 (UMLS CUI [1,2])
Ventricular Dysfunction, Left | echocardiography: left ventricular ejection fraction
Item
left ventricular dysfunction (echocardiographic left ventricular ejection fraction < 25%)
boolean
C0242698 (UMLS CUI [1])
C2097013 (UMLS CUI [2])
Stenting Bifurcation lesion Branch of artery Both
Item
stenting both branch of bifurcation lesion
boolean
C2348535 (UMLS CUI [1,1])
C1299363 (UMLS CUI [1,2])
C0500459 (UMLS CUI [1,3])
C1706086 (UMLS CUI [1,4])
Lesion Left coronary artery main stem
Item
left main trunk lesion
boolean
C0221198 (UMLS CUI [1,1])
C0226031 (UMLS CUI [1,2])
Graft Vessel
Item
graft vessels
boolean
C0332835 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
clopidogrel Due to Other medical condition
Item
patients who have to receive clopidogrel due to other conditions
boolean
C0070166 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
Warfarin | cilostazol | Antiplatelet therapy
Item
patients who have to receive warfarin, cilostazol or other antiplatelet therapy
boolean
C0043031 (UMLS CUI [1])
C0055729 (UMLS CUI [2])
C1096021 (UMLS CUI [3])
Kidney Failure, Chronic | Creatinine measurement, serum
Item
patient with chronic renal failure (s-cr > 2.0 mg/dl)
boolean
C0022661 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Hypersensitivity clopidogrel | Aspirin allergy
Item
hypersensitivity to clopidogrel or aspirin
boolean
C0020517 (UMLS CUI [1,1])
C0070166 (UMLS CUI [1,2])
C0004058 (UMLS CUI [2])
Life Expectancy
Item
expectant survival less than 1 year
boolean
C0023671 (UMLS CUI [1])
Pregnancy, Planned
Item
women who plan to become pregnant
boolean
C0032992 (UMLS CUI [1])
Bleeding tendency | Blood Coagulation Disorders | Thrombocytopenia | Platelet dysfunction | Gastrointestinal Hemorrhage | Hemorrhage Genitourinary
Item
patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, gastrointestinal or genitourinary bleeding within the prior 3 months)
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0040034 (UMLS CUI [3])
C0679429 (UMLS CUI [4])
C0017181 (UMLS CUI [5])
C0019080 (UMLS CUI [6,1])
C3887515 (UMLS CUI [6,2])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])